- Telehealth Visits
- Insurance plan information
Lily Kornbluth, MD
Internal Medicine- Telehealth Visits
- Insurance plan information
Lily Kornbluth, MD
Internal Medicine- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Lily Kornbluth is an internal medicine specialist who provides primary and urgent care for adults.
Kornbluth earned her medical degree at the David Geffen School of Medicine at UCLA. She completed a residency in internal medicine at UCSF.
Education & training
Board certification
- Internal Medicine, American Board of Internal Medicine
Residency
- Internal Medicine, UCSF School of Medicine -GME
Internship
- Internal Medicine, UCSF Medical Center - OMAG
Degree
- MD, UCLA David Geffen School of Medicine
Academic title
- Health Sciences Clinical Professor
My expertise
Specialties
My research
Publications
Showing 1-6 of 46 reviews
- May 13, 20265 out of 5 Stars
Dr Kornbluth is excellent!!!!!
- May 4, 20265 out of 5 Stars
Proactive thoughtful discussion with physician, who had clearly prepared for our visit in advance - informed about blood tests, fully aware of prior concerns and addressed any issues that had arisen in the preceeding year. Informative yet a very p ersonal discussion of options and various modalities to address issues. Consider myself extremely lucky to be Dr. Kornbluth's patient.
- April 21, 20265 out of 5 Stars
I Feel so confident with my Dr Lily Kornbluth!
- April 21, 20265 out of 5 Stars
Dr Kornbluth is an excellent doctor!
- April 19, 20265 out of 5 Stars
Absolutely outstanding
- April 9, 20265 out of 5 Stars
Dr Kornbluth is amazing!! Great doctor!!!!
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.